Current Pharmacogenomics and Personalized Medicine
Title: Editorial (Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine)
Volume: 9 Issue: 1
Author(s): Vural Ozdemir, David H. Muljono, Tikki Pang, Lynnette R. Ferguson, Aresha Manamperi, Sofia Samper, Toshiyuki Someya, Anne Marie TassE, Shih-Jen Tsai, Hong-Hao Zhou and Edmund J.D. Lee
Affiliation:
Keywords: Asia-Pacific, genomics and international development, global health, health 2020 policy, knowledge co-production, LMICs, public health genomics, science and society, theragnostics, cultural lags
Export Options
About this article
Cite this article as:
Ozdemir Vural, H. Muljono David, Pang Tikki, R. Ferguson Lynnette, Manamperi Aresha, Samper Sofia, Someya Toshiyuki, Marie TassE Anne, Tsai Shih-Jen, Zhou Hong-Hao and J.D. Lee Edmund, Editorial (Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine), Current Pharmacogenomics and Personalized Medicine 2011; 9 (1) . https://dx.doi.org/10.2174/187569211794728841
DOI https://dx.doi.org/10.2174/187569211794728841 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Mulberry on The Central Nervous System: A Literature Review
Current Neuropharmacology Sepsis, Coagulation and Anticoagulants
Endocrine, Metabolic & Immune Disorders - Drug Targets Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
Current Pharmaceutical Design Autophagy Modulators and Neuroinflammation
Current Medicinal Chemistry A Legend in Neuroscience (1948-2018) Dr. Stephen D. Skaper, Ph. D
CNS & Neurological Disorders - Drug Targets Using Metabolomics for Elucidating the Mechanisms Related to Tuberculosis Treatment Failure
Current Metabolomics Propranolol Safety Profile in Children
Current Drug Safety Editorial [ Hot Topic : Receptor Dimerization and Bivalent Ligands, an Emerging Topic for Drug Design (Guest Editor: Dr. Ao Zhang) ]
Current Topics in Medicinal Chemistry Predicting Protein Fold Types by the General Form of Chou's Pseudo Amino Acid Composition: Approached from Optimal Feature Extractions
Protein & Peptide Letters Editorial [Hot Topic: An Update on Neurotrophins (Guest Editor: Celia Duarte Cruz)]
Current Neuropharmacology The Opioid Receptor Independent Actions of Kappa Receptor Agonists in the Cardiovascular System
Current Pharmaceutical Design Trafficking of Neuronal Two Pore Domain Potassium Channels
Current Neuropharmacology Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling
Current Medicinal Chemistry Central Nervous System Manifestations in Systemic Lupus Erythematosus
Current Rheumatology Reviews Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections
Current Pharmaceutical Design Alkylglycerol Lipid Precursors: A Review of Therapeutic Strategies for Plasmalogen Replacement
Current Organic Chemistry Review of 5-HT4R Ligands: State of Art and Clinical Applications
Current Topics in Medicinal Chemistry Plasma Clusterin as a Potential Biomarker for Alzheimer’s Disease-A Systematic Review and Meta-analysis
Current Alzheimer Research The Role of ER Stress-Induced Apoptosis in Neurodegeneration
Current Alzheimer Research 21.1 Tesla Magnetic Resonance Imaging Apparatus and Image Interpretation: First Report of a Scientific Advancement
Recent Patents on Medical Imaging